4.7 Review

Low Testosterone Associated With Obesity and the Metabolic Syndrome Contributes to Sexual Dysfunction and Cardiovascular Disease Risk in Men With Type 2 Diabetes

Journal

DIABETES CARE
Volume 34, Issue 7, Pages 1669-1675

Publisher

AMER DIABETES ASSOC
DOI: 10.2337/dc10-2339

Keywords

-

Funding

  1. GlaxoSmithKline
  2. Repros Therapeutics
  3. Bayer-Schering Pharma
  4. Lilly
  5. Repros
  6. Clarus Therapeutics
  7. Abbott (Solvay)

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available